Advertisement
Home2024-01-11T09:26:42-05:00

Top Story

  • Real World Data
    May 20th, 2024

    ⁤Online misinformation has had severe public health consequences, in particular about the COVID-19 vaccine. ⁤⁤While it is challenging to scientifically confirm the direct impact of misinformation, a new study led by Eugenia Rho from Virginia Tech has made strides using data from Reddit. ⁤⁤By analyzing thousands [...]

HEOR

RWE

Market Access

Advertisement

Featured Webinars

Handpicked Promotions & Highlights

Latest in Catalyst News powered by BioPharmCatalyst

05/17/2024 04:45 PM ET

Vaccinex VCNX date announcement

On June 30, 2024, Vaccinex will announce top-line results for their recent Phase 1/2 trial for Pepinemab - (SIGNAL-AD). Our calculations give the drug a 60.7% chance of moving on to the next stage.

The [...]

Read More
05/17/2024 04:45 PM ET

Dermata Therapeutics AZTR date announcement

Azitra, makers of ATR-04, will be announcing their top-line results for the drug's recent Preclinical trial on May 24, 2024. As of now, the drug has a 85% chance of moving on.

The announcement [...]

Read More
05/17/2024 04:45 PM ET

Erasca ERAS results announcement

Erasca, makers of ERAS-4001, have released new information on its trial. Our analysts summarized the update as follows:

"Preclinical development ongoing."

Erasca rocketed up $0.12 (+6.49%) to $1.97 on light volume today. Despite [...]

Read More
05/17/2024 04:45 PM ET

Oragenics XCUR earnings announcement

Exicure revealed their most recent quarterly earnings data for Q3. EPS was reported to be -$0.61.

Investors weren’t very happy with the news. Exicure declined significantly, decreasing $0.02 (-4.53%) to $0.50 on light volume [...]

Read More

Latest From Our Blog

Receive essential insights, resources and content direct to your inbox

Hit subscribe to stay informed!

Go to Top